Basepoint (LSE:BNT)
Historical Stock Chart
From Oct 2019 to Oct 2024
Bentley Pharmaceuticals to Present at the UBS Global Specialty
Pharmaceuticals Conference
EXETER, N.H., May 24 /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals, Inc. ,
a specialty pharmaceutical company focused on advanced drug-delivery
technologies, which also manufactures and markets generic and branded products
in Europe, announced today that Michael D. Price, Vice President and Chief
Financial Officer of the Company, will be presenting at the UBS Global
Specialty Pharmaceuticals Conference at the Grand Hyatt in New York, NY. The
presentation is scheduled for Tuesday, May 25, 2004 at 3:00 p.m. (EDT).
The presentation will be broadcast live over the Internet and may be accessed
via the Company's website, http://www.bentleypharm.com/. In addition, a replay
of the presentation will be available beginning three hours after the
presentation time and will remain available through June 27, 2004. Follow the
above instructions to access the replay.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on
advanced drug delivery technologies and pharmaceutical products. Bentley's
proprietary drug technologies enhance or facilitate the absorption of
pharmaceutical compounds across various membranes. Bentley also manufactures
and markets a growing portfolio of generic and branded pharmaceuticals in
Europe for the treatment of cardiovascular, gastrointestinal, infectious and
neurological diseases through its subsidiaries, Laboratorios Belmac,
Laboratorios Davur and Laboratorios Rimafar; and manufactures and sells active
pharmaceutical ingredients through its subsidiary, Bentley API.
Copies of Bentley Pharmaceuticals' press releases and other information may be
obtained through Bentley's web site at http://www.bentleypharm.com/.
DATASOURCE: Bentley Pharmaceuticals, Inc.
CONTACT: Michael D. Price, Vice President, Chief Financial Officer of
Bentley Pharmaceuticals, Inc., +1-603-658-6100; Investors - Jonathan Birt,
Lanie Marcus or Media - Sean Leous, all of Financial Dynamics,
+1-212-850-5600, for Bentley Pharmaceuticals, Inc.
Web site: http://www.bentleypharm.com/